Safe transfusion for transplant patients
July 2026
This article outlines what makes transfusion practice in transplant patients distinct, drawing on analysis of reports submitted to the Serious Hazards of Transfusion (SHOT) UK haemovigilance scheme. It highlights the common risks and describes practical, system‑level improvements to enhance transfusion safety throughout the transplant pathway.
Also of interest
-
Gene therapy in sickle cell and thalassaemia – where cutting-edge science meets clinical need
What does the approval for human use of new gene editing techniques mean for patients?